查詢結果分析
來源資料
相關文獻
- System-based Strategy for the Management of Meconium Aspiration Syndrome: 198 Consecutive Cases Observations
- Risk Factors of Meconium Aspiration Syndrome Developing into Persistent Pulmonary Hypertension of Newborn
- Risk Factors of Mortality in Meconium Aspiration Syndrome: Review of 314 Cases
- Comparison of the Outcome of Extremely-Low-Birth-Weight Infants between Two Periods
- 精神科專科醫院急性住院患者之死亡率
- 臺灣地區死亡率現況的實證研究
- Factors Affecting the Mortality of Sick Newborns Admitted to intensive Care Units
- 機動車事故傷害發生地、死亡地與戶籍地關係之初探:花東經驗
- 我國出生通報制度建立後對嬰兒死亡率之影響分析
- 臺灣歷史上的疾病與死亡
頁籤選單縮合
題 名 | System-based Strategy for the Management of Meconium Aspiration Syndrome: 198 Consecutive Cases Observations=以系統性策略治療胎便吸入症候群:連續198例之結果 |
---|---|
作 者 | 林鴻志; 蘇百弘; 林宗文; 蔡長海; 葉純甫; | 書刊名 | 臺灣兒科醫學會雜誌 |
卷 期 | 46:2 民94.03-04 |
頁 次 | 頁67-71+115 |
分類號 | 417.517 |
關鍵詞 | 胎便吸入症候群; 新生兒持續性肺動脈高壓; 氣胸; 死亡率; Meconium aspiration syndrome; Persistent pulmonary hypertension; Pneumothorax; Mortality; |
語 文 | 英文(English) |
英文摘要 | To evaluate whether the system-based strategy for management of meconium aspiration syndrome (MAS) could reduce the morbidity and mortality rate of MAS in our institute, a prospective consecutive clinical observation was conducted. System-based strategy including appropriately trained the relevant medical staff to familiar with neonatal resuscitation program, early surfactant replacement or lavage following with high-frequency ventilator (HFV) and/or inhaled nitric oxide (iNO). Outcome measurements were the morbidity and mortality rates of MAS. All infants of MAS in the study period were included except cases of congenital malformations or cyanotic congenital heart disease (CHD). Oxygen, nasal continuous positive airway pressure (CPAP), and intermittent mandatory ventilation (IMV) were applied as clinically indicated. Surfactant was used as replacement or lavage therapy for MAS infants whose oxygen index (OI) exceeded 20 or value for AaDO2 exceeded 400 within 6 hours of age. High-frequency oscillator ventilation (HFO) was applied for infants of MAS that demonstrated intractable respiratory failure with conventional mechanical ventilation and 100% oxygen. Inhaled nitric oxide (iNO) was used with IMV or HFO for infants of persistent pulmonary hypertension (PPHN) when it was unresponsive to conventional therapy. Dexamethasone was prescribed in infants of severe hypotension that did not respond to dopamine and epinephrine. A series of 198 consecutive infants of MAS born in this hospital during 9 years were analyzed. There was no mortality. Fourteen infants developed PPHN, 11 had pneumothorax, 1 had pulmonary hemorrhage, 2 had neurologic sequelae because of severe asphyxia, and 2 developed bronchopulmonary dysplasia. Our results indicated that appropriately trained relevant medical staff with neonatal resuscitation program to avoid complicated MAS and early surfactant replacement or lavage following with HFO and/or iNO could reduce the morbidity and mortality rate of MAS even without extracorporeal membrane oxygenation (ECMO). |
本系統中英文摘要資訊取自各篇刊載內容。